Some rare studies have however focused on the importance of other sources of estrogens, and in particular on 5-diol, a C19-steroid that more weakly binds ERα, but whose importance is believed to become more pronounced after menopause, especially in breast tumor growth. Here, ESR1 is linked to breast neoplasm.